MOORE CAPITAL MANAGEMENT, LP - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 280 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.

Quarter-by-quarter ownership
MOORE CAPITAL MANAGEMENT, LP ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2022$14,943,000
+260.9%
226,782
+486.7%
0.35%
+328.0%
Q4 2021$4,140,000
-75.6%
38,654
-76.6%
0.08%
-68.3%
Q3 2021$16,971,000
-0.6%
165,069
-15.0%
0.26%
+7.0%
Q2 2021$17,080,000
+50.3%
194,183
+66.1%
0.24%
+69.2%
Q1 2021$11,367,000
-50.7%
116,911
-43.1%
0.14%
-43.5%
Q4 2020$23,042,000
+107.7%
205,454
+71.7%
0.25%
+19.3%
Q3 2020$11,092,000
+468.8%
119,652
+378.6%
0.21%
+307.7%
Q2 2020$1,950,000
-26.1%
25,000
-28.6%
0.05%
+8.3%
Q4 2017$2,639,00035,0000.05%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 423,012$41,129,0007.43%
Eagle Health Investments LP 133,163$12,947,0005.08%
DAFNA Capital Management LLC 207,911$20,215,0004.80%
Casdin Capital, LLC 1,550,000$150,707,0004.49%
SIB LLC 65,151$6,335,0003.72%
CADIAN CAPITAL MANAGEMENT, LP 913,702$88,839,0003.29%
Integral Health Asset Management, LLC 117,500$11,425,0003.26%
Rock Springs Capital Management LP 746,732$72,605,0001.58%
Avidity Partners Management LP 546,000$53,088,0001.47%
Zebra Capital Management LLC 12,698$1,235,0001.36%
View complete list of BLUEPRINT MEDICINES CORP shareholders